This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Singer, S. H. Articles by Kirschstein, R. L. Search for Related Content PubMed PubMed Citation Articles by Singer, S. H. Articles by Kirschstein, R. L.

Respiratory Diseases in Cyclophosphamide-Treated Mice I. Increased Virulence of Mycoplasma pulmonis

¹ Laboratory of Pathology, Division of Biologics Standards, National Institutes of Health, Bethesda, Maryland 20014

ABSTRACT

Mice infected intranasally with Mycoplasma pulmonis were treated with cyclophosphamide, a potent immunologic suppressor. In place of a chronic smouldering infection with little mortality (2%), a rapidly lethal infection with high mortality (66%) was produced. M. pulmonis was able to be isolated from several organs during the course of the unmodified infection. In the infected animals treated with cyclophosphamide, dissemination occurred earlier, and higher titers of mycoplasma were found. Reconstitution experiments with spleen cells from previously infected animals reversed the effect of cyclophosphamide, indicating that immunity plays an important role in containment of the infection and eventual recovery.